Literature DB >> 7681256

Expression of bcl-2 in fetal tissues suggests a role in morphogenesis.

D P LeBrun1, R A Warnke, M L Cleary.   

Abstract

We have studied the distribution of the bcl-2 protein in fetal tissues, in an effort to uncover patterns of expression that may elucidate the potential role of bcl-2 during development. We find that bcl-2 is expressed in many hematolymphoid and non-hematolymphoid tissues, most abundantly in placental trophoblast. In tissues of endocrine and neural derivation and in stem-cell populations of colonic and some stratified epithelia, bcl-2 seems to be involved in tissue homeostasis. However, in developing proximal nephrons of the kidney and other sites characterized by inductive interactions between epithelium and mesenchyme, bcl-2 is apparently involved in morphogenesis, possibly by mediating the formation of condensations of cells that are "committed" to the formation of more differentiated structures. The distribution of bcl-2-protein expression in fetal tissues is consistent with its previously described role in promoting cell survival, presumably by preventing apoptosis in lymphoid and other tissues where cell death represents an active regulatory process. Expression of bcl-2 protein is more widespread in fetal than adult tissues. Our observations therefore represent supportive evidence for the importance of inducible cell survival as a regulatory process in normal homeostasis and morphogenesis in many fetal tissues and structures.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681256      PMCID: PMC1886804     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

Review 1.  Transforming growth factor-beta--mullerian inhibiting substance family of growth regulators.

Authors:  M A Liu; A Oliff
Journal:  Cancer Invest       Date:  1991       Impact factor: 2.176

2.  The cellular basis of hearing: the biophysics of hair cells.

Authors:  A J Hudspeth
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

3.  Advantages of detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in Coplin jars.

Authors:  J M Bindl; R A Warnke
Journal:  Am J Clin Pathol       Date:  1986-04       Impact factor: 2.493

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.

Authors:  A Bakhshi; J P Jensen; P Goldman; J J Wright; O W McBride; A L Epstein; S J Korsmeyer
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

6.  Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.

Authors:  M L Cleary; S D Smith; J Sklar
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

7.  Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.

Authors:  Y Tsujimoto; L R Finger; J Yunis; P C Nowell; C M Croce
Journal:  Science       Date:  1984-11-30       Impact factor: 47.728

8.  Regressive events in neurogenesis.

Authors:  W M Cowan; J W Fawcett; D D O'Leary; B B Stanfield
Journal:  Science       Date:  1984-09-21       Impact factor: 47.728

9.  Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma.

Authors:  J J Yunis; M M Oken; M E Kaplan; K M Ensrud; R R Howe; A Theologides
Journal:  N Engl J Med       Date:  1982-11-11       Impact factor: 91.245

10.  The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining.

Authors:  Y Tsujimoto; J Gorham; J Cossman; E Jaffe; C M Croce
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

View more
  62 in total

1.  Transcriptional analysis of human survivin gene expression.

Authors:  F Li; D C Altieri
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

Review 2.  Driving apoptosis-relevant proteins toward neural differentiation.

Authors:  Susana Solá; Márcia M Aranha; Cecília M P Rodrigues
Journal:  Mol Neurobiol       Date:  2012-07-01       Impact factor: 5.590

3.  Expression of bcl-2 in bladder neoplasms is a cell lineage associated and p53-independent event.

Authors:  Q L Lu; M Laniado; P D Abel; G W Stamp; E N Lalani
Journal:  Mol Pathol       Date:  1997-02

4.  Bcl-2 expression is essential for development and normal physiological properties of tooth hard tissue and saliva production.

Authors:  Mohammad Ali Saghiri; Armen Asatourian; Zafer Gurel; Christine M Sorenson; Nader Sheibani
Journal:  Exp Cell Res       Date:  2017-06-10       Impact factor: 3.905

5.  Bcl-2 expression in colorectal tumors: evidence of different pathways in sporadic and ulcerative-colitis-associated carcinomas.

Authors:  M Ilyas; I P Tomlinson; A M Hanby; T Yao; W F Bodmer; I C Talbot
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

6.  BCL2 regulates neural differentiation.

Authors:  K Z Zhang; J A Westberg; E Hölttä; L C Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

7.  bcl-2 protein expression in tumors of the central nervous system.

Authors:  S Nakasu; Y Nakasu; H Nioka; M Nakajima; J Handa
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Bcl-2 protein expression during murine development.

Authors:  D V Novack; S J Korsmeyer
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

9.  bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death.

Authors:  M González-García; I García; L Ding; S O'Shea; L H Boise; C B Thompson; G Núñez
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

Review 10.  Programmed cell death and radioresistance.

Authors:  R E Meyn; L C Stephens; L Milas
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.